U.S. markets open in 6 hours 13 minutes
  • S&P Futures

    4,222.75
    +12.75 (+0.30%)
     
  • Dow Futures

    33,360.00
    +100.00 (+0.30%)
     
  • Nasdaq Futures

    13,450.75
    +58.75 (+0.44%)
     
  • Russell 2000 Futures

    1,975.90
    +6.40 (+0.32%)
     
  • Crude Oil

    91.72
    -0.21 (-0.23%)
     
  • Gold

    1,801.50
    -12.20 (-0.67%)
     
  • Silver

    20.49
    -0.26 (-1.24%)
     
  • EUR/USD

    1.0319
    +0.0017 (+0.17%)
     
  • 10-Yr Bond

    2.7860
    0.0000 (0.00%)
     
  • Vix

    19.74
    -2.03 (-9.32%)
     
  • GBP/USD

    1.2230
    +0.0012 (+0.10%)
     
  • USD/JPY

    132.6380
    -0.2350 (-0.18%)
     
  • BTC-USD

    24,556.83
    +1,599.59 (+6.97%)
     
  • CMC Crypto 200

    577.70
    +46.48 (+8.75%)
     
  • FTSE 100

    7,497.14
    -9.97 (-0.13%)
     
  • Nikkei 225

    27,819.33
    -180.63 (-0.65%)
     

Viatris keen to increase dividends

·2 min read
Viatris keen to increase dividends
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Canonsburg-based drug manufacturer Viatris Inc. said its initial return to shareholders in 2022 will come in the form of dividends, with CEO Michael Goettler not completely shutting the door on stock buybacks but saying the latter was a more complex issue. Viatris (NYSE: VTRS), which will turn a year old next week, is the combination of Mylan NV and the Upjohn unit of Pfizer Inc. (NYSE: PFE). Viatris had earnings of $311.5 million, 26 cents a share, on revenue of $4.5 billion, compared to $185.7 million, 36 cents a share, on revenue of $2.9 million for Mylan and Upjohn a year ago.